Chih-Yuan Chung
Overview
Explore the profile of Chih-Yuan Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen M, Chou S, Chiou S, Lin P, Chen Y, Lin H, et al.
Haemophilia
. 2023 Oct;
29(6):1499-1508.
PMID: 37819166
Introduction: Emicizumab mimicking the cofactor function of activated factor VIII (FVIII) restores haemostasis. Methods: This nationwide observational study aimed to retrospectively investigate efficacy, safety, and cost in 1 year before...
2.
Liang J, Lee P, Ku C, Chen W, Chung C, Kuo Y, et al.
Cancer Manag Res
. 2021 Apr;
13:3465-3472.
PMID: 33907469
Purpose: Image-guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the radiotherapy delivery. We aimed to compare the overall survival (OS) for localized breast cancer (LBC) patient treated with...
3.
Li C, Liang J, Chung C, Chen W, Chien C
Anticancer Res
. 2019 Mar;
39(3):1479-1484.
PMID: 30842185
Background/aim: Neoadjuvant concurrent chemoradiotherapy (nCCRT) is the standard of care for locally advanced rectal cancer (LARC) patients treated with neoadjuvant concurrent chemoradiotherapy (nCCRT). The aim of this study was to...
4.
Chen C, Chung C, Wang L, Lin C, Lin H, Lin H
BMC Cancer
. 2015 Apr;
15:133.
PMID: 25885746
Background: The burden of cancer is likely to increase among the human immunodeficiency virus (HIV)-positive population as it ages due to successful antiretroviral therapy (ART). The purpose of this study...
5.
Chung C, Lin S, Chen P, Chang M, Kao W, Chao T, et al.
Anticancer Res
. 2012 Jul;
32(8):3415-9.
PMID: 22843924
Background: Thalidomide inhibits angiogenesis and exerts complex immunomodulatory activities. This phase II study aimed to examine the efficacy of thalidomide in Taiwanese patients with myelodysplastic syndrome (MDS). Patients And Methods:...
6.
Ho M, Chung C, Wang C, Lin H, Hsu N, Chang C
Saudi Med J
. 2010 Dec;
31(12):1315-9.
PMID: 21135993
Objective: We evaluated the analgesic efficacy and safety of tramadol 37.5 mg/acetaminophen 325 mg combination tablet, for the treatment of breakthrough pain in cancer patients. Methods: This study was conducted...
7.
Wu K, Yeh C, Hung C, Chung C, Cheng L
J Nanosci Nanotechnol
. 2010 Apr;
10(2):1057-64.
PMID: 20352756
This paper aims to characterize the photoelectrochemical properties of the visible-light enabling titanium dioxide (TiO2) film electrodes prepared by codoping nitrogen (N) and a presputtered carbon film (C-film) onto indium...
8.
Wu Y, Chang C, Chung C, Lin H, Wang C, Shen M
Int J Hematol
. 2009 Jul;
90(2):170-173.
PMID: 19588218
Since superwarfarin is popular and readily available in stores, it may cause intoxication or overexposure, which can result in coagulopathy or abnormal bleeding in humans and, thus, is an important...
9.
Hwang W, Chao T, Lin S, Chung C, Chiu C, Chang Y, et al.
Anticancer Drugs
. 2008 May;
19(3):283-8.
PMID: 18510174
This study was designed to determine the efficacy and safety of biweekly oxaliplatin in combination with infusional 5-fluouracil (5-FU) and leucovorin in patients with advanced gastric cancer (AGC). Fifty-five eligible...
10.
Perng R, Yang C, Chen Y, Chang G, Lin M, Hsieh R, et al.
Lung Cancer
. 2008 Apr;
62(1):78-84.
PMID: 18423781
Purpose: Erlotinib is the first epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) which has demonstrated a survival benefit in non-small-cell lung cancer (NSCLC) patients. An open label phase II study...